Glykanipin
Glykanipin is a synthetic cannabinoid receptor agonist, which means it binds to and activates cannabinoid receptors in the body. It was developed as a potential treatment for various conditions, including pain, inflammation, and anxiety. Glykanipin is structurally similar to other cannabinoids, such as THC and CBD, but it has a unique chemical composition that distinguishes it from these compounds.
The primary mechanism of action of glykanipin involves the activation of cannabinoid receptors, particularly CB1 and
Glykanipin has been studied for its potential therapeutic benefits, but its use is still relatively limited